Inside the Current Issue

Cover Story
Basic instincts drive Mountain States’ forward momentum

Self Study Series

Newswire
Purchasing Connection
Resources
Show Calendar
H HPN Hall of Fame
HPN ProductLink
Classifieds
Issue Archives
Advertise
About Us Home
Subscribe
Special Event Photos

Contact Us

KSR Publishing, Inc.
Copyright © 2009

People, Places, Processes & Products that Influence the Supply Chain

hpnonline Daily Update

October 2008
 
October 13 October 14 October 15 October 16 October 17

 

October 17, 2008   Download print version

Ties between doctors and stent makers queried

NJ flu-shot mandate for preschoolers draws outcry

Flu shots a tough sell to healthcare workers

Docs find 'Stayin Alive' lives up to its name, with a great beat for reviving stopped hearts

TSO3 announces agreement with MAGNET

B. Braun presents education guide for best practice in anesthesia

CDC collaborates on Preventing Skin Infections program with wrestling coaches

Munson Healthcare signs Multi-Suite Lawson Software contract


Ties between doctors and stent makers queried

Heart doctors and makers of medical devices meeting for their annual convention here got a sobering piece of news on Thursday — two senators are asking tough questions about financial ties between the doctors and the companies. Charles E. Grassley, Republican of Iowa, and Herb Kohl, Democrat of Wisconsin, sent a letter asking the nonprofit group that sponsors the conference, the Cardiovascular Research Foundation, for information about its financial relationships with device manufacturers and drug producers.

The senators also sent a letter to Columbia University, which has an affiliation with the Cardiovascular Research Foundation. In a statement, the foundation said it would “comply fully” with the information request. “C.R.F. is committed to maintaining the highest standards of integrity in all of its research and educational activities and ensuring independence, objectivity and scientific rigor in all of its programs,” the statement said. According to the foundation’s most recent tax filing on the website guidestar.org, it had revenue in 2005 of $47.2 million.

Columbia University Medical Center issued a statement saying it would respond to the request for information. “It is important to note that Columbia University and its Medical Center have conflict of interest policies and procedures in place, and we expect that they are followed by all members of the faculty," the statement said.

The manufacturers cited in the senators’ letters are Abbott Laboratories, Medtronic, Boston Scientific, Johnson & Johnson and Medinol.

The annual conference here, known as Transcatheter Cardiovascular Therapeutics (TCT), has attracted hundreds of doctors from around the world who specialize in using devices that are placed in the body through catheters, most notably heart stents. At the meeting, manufacturers of stents and related surgical products or drugs display their products in an exhibition hall.

The letters sent Thursday are part of a recent wave of inquiries by Senators Grassley and Kohl into potential conflicts of interests between medical researchers and drug and device companies. The lawmakers are also among those sponsoring legislation that would require the industry to more fully disclose such financial ties.

At the same conference on Thursday, researchers released results of a new study indicating that a drug-coated stent called Endeavor, made by Medtronic, was linked to more heart attacks and deadly blood clots than the Cypher stent made by Johnson & Johnson. Shares of the medical device maker Medtronic fell Thursday. Results from the study, which included more than 2,000 patients, showed that heart patients who received the Medtronic device, called Endeavor, had more heart attacks and blood clots and needed repeat procedures more often than those treated with the Johnson & Johnson Cypher stent. (The New York Times)  Read the complete story

Visit here for the complete Medtronic story

 

NJ flu-shot mandate for preschoolers draws outcry

AP - Many New Jersey parents are furious over a first-in-the-nation requirement that children get a flu shot in order to attend preschools and day-care centers. The decision should be the parents', not the state's, they contend. Hundreds of parents and other activists rallied outside the New Jersey Statehouse on Thursday, decrying the policy and voicing support for a bill that would allow parents to opt out of mandatory vaccinations for their children.

New Jersey's policy was approved last December by the state's Public Health Council and is taking effect this fall. Children from 6 months to 5 years old who attend a child-care center or preschool have until Dec. 31 to receive the flu vaccine, along with a pneumococcal vaccine. The Health Council was acting on the recommendations of the Centers for Disease Control and Prevention (CDC), which has depicted children under 5 as a group particularly in need of flu shots. But no other state has made the shots mandatory for children of any age.

Opposition to the policy is vehement. Assemblywoman Charlotte Vandervalk, one of the speakers at the rally, said she now has 34 co-sponsors for a bill that would allow for conscientious objections to mandatory vaccinations. “The right to informed consent is so basic," she said in an interview. "Parents have a right to decide for their own children what is injected in their bodies."

State policy now allows for medical and religious exemptions to mandatory vaccinations, but Vandervalk said requests for medical exemptions often have been turned down by local health authorities. She said 19 other states allow conscientious exemptions like those envisioned in her bill.

State health officials and the CDC insist the flu vaccine is safe and effective, but Vandervalk and the parent groups who support her bill contend there has been inadequate research into the vaccine's impact on small children. Critics note that flu vaccines contain trace amounts of thimerosol, a mercury-based preservative; the CDC says there's no convincing evidence these trace amounts cause harm. (Washington Post- Associated Press)   Read the complete story

 

Flu shots a tough sell to healthcare workers

AP - Operating room nurse Pauline Taylor from University Hospitals and Clinics in Iowa City, knows her refusal to get a flu shot is based on faulty logic. But ever since she got sick after getting a shot a few years ago, she's sworn off the vaccine.

Such stories frustrate Dr. William Schaffner. As chairman of the Department of Preventive Medicine at Vanderbilt University, he hears that kind of talk frequently and knows it's in part to blame for a surprising statistic - nearly 60 percent of health- care workers fail to get a flu shot.

That's despite recommendations from the CDC that all healthcare workers get vaccinated, from hospital volunteers to doctors.

"It is a professional obligation on the part of health care workers to make sure that they are as protected against influenza as possible," Schaffner said. Schaffner argues that getting vaccinated for the flu should be standard for doctors and nurses, just like washing their hands. That's because the flu virus can be spread so easily.

"Being in close proximity to patients, having conversations with them, bending over their bed, seeing them in the clinic while you're doing procedures, you would be breathing out viruses and spreading influenza into your patients," said Schaffner, who is also president-elect of the National Foundation for Infectious Diseases.

The nonprofit group educates the public and healthcare industry about the causes, treatment and prevention of infectious diseases. It gets about 75 percent of its budget from major vaccine makers, but executive director Len Novick said the money comes with no strings attached.

According to the foundation, likely cases of flu outbreaks between healthcare workers and patients include: 19 babies in a neonatal intensive care unit in Ontario, Canada, infected in 2000; one died. Healthcare workers, only 15 percent of whom were immunized, were the likely source. 65 residents of a nursing home in New York got the flu during the 1991-1992 flu season, and two died. Only 10 percent of healthcare workers had been vaccinated before the outbreak, according to a report by the CDC.

The CDC recommends that health care facilities offer free flu vaccines to employees annually at work, and that hospitals obtain signed statements from workers who refuse.

Several states have laws requiring hospitals to make the vaccines available. At Allen Hospital in Waterloo, Iowa, the flu shot is mandatory for those with direct patient contact and recommended for everyone else. Those with allergies to the vaccine or other conditions can take a pass, but they must supply a note from their doctor. The hospital says the vaccination rate is 93 percent.

Some hospitals take a tougher stand on vaccinations. In Seattle, at Virginia Mason Medical Center, even sales reps, vendors and volunteers must be vaccinated unless they seek exceptions for religious or medical reasons. Even then, those who don't get a shot must wear a mask whenever they are in the hospital during the flu season. About 99 percent of the hospital's more than 5,000 employees were vaccinated. (Miami Herald – Associated Press)  Read the complete article

 

Docs find 'Stayin Alive' lives up to its name, with a great beat for reviving stopped hearts

"Stayin' Alive" might be more true to its name than the Bee Gees ever could have guessed: At 103 beats per minute, the old disco song has almost the perfect rhythm to help jump-start a stopped heart. And in a small but intriguing study from the University of Illinois medical school, doctors and students maintained close to the ideal number of chest compressions doing CPR while listening to the catchy, sung-in-falsetto tune from the 1977 movie "Saturday Night Fever."

The American Heart Association recommends 100 chest compressions per minute, far more than most people realize, study author Dr. David Matlock of the school's Peoria, IL, campus said Thursday. And while CPR can triple cardiac arrest survival rates when properly performed, many people hesitate to do it because they're not sure about keeping the proper rhythm, Matlock said.

He found that "Stayin' Alive," which has a way of getting stuck in your head anyway, can help with that. His study involved 15 students and doctors and had two parts. First they did CPR on mannequins while listening to the song on iPods. They were asked to time chest compressions with the song's beat.

"It drove them and motivated them to keep up the rate, which is the most important thing," he said. The study showed the song helped people who already know how to do CPR, and the results were promising enough to warrant larger, more definitive studies with real patients or untrained people, Matlock said.

It turns out the American Heart Association has been using the song as a training tip for CPR instructors for about two years. They learned of it from a physician "who sort of hit upon this as a training tool," said association spokesman Dr. Vinay Nadkarni of the University of Pennsylvania. He said he was not aware of any previous studies that tested the song.

Nadkarni said he has seen "Stayin' Alive" work wonders in classes where students were having trouble keeping the right beat while practicing on mannequins. When he turned on the song, "all of a sudden, within just a few seconds, they get it right on the dot."  ( ABC News -  Associated Press) Read the complete story

American Heart Association: http://www.americanheart.org/handsonlycpr

 

TSO3 announces agreement with MAGNET

Mr. W. Barry McDonald, Interim President and CEO of TSO3 Inc., is proud to announce that TSO3 has been selected as a vendor partner by the Mid-Atlantic Group Network of Shared Services (MAGNET), one of the oldest and largest group purchasing organizations in the United States. East coast-based MAGNET, serves 11,000 healthcare providers by offering access to a contract portfolio of high-quality capital equipment and services. As a vendor partner, TSO3 will supply MAGNET’s members with its low temperature ozone sterilization system for hospital environments. Significant sales are anticipated in the near-term as a result of this agreement. For more information, visit www.tso3.com.

 

B. Braun presents education guide for best practice in anesthesia

B. Braun Medical Inc. (B. Braun) has announced the publication of a first-of-its-kind educational guide, Dual Guidance – A Multimodal Approach to Nerve Location. The educational guide will be introduced at the 2008 Annual Meeting of the American Society of Anesthesiologists (ASA), to be held Oct. 19-21 in Orlando.

Authored by three key opinion leaders in the anesthesiology field – Drs. Ralf Gebhard, William Urmey, and Admir Hadzic, with an introduction from Dr. Richard Brull – the four-chapter information resource defines the concept of “dual guidance,” or the use of ultrasound with nerve stimulation, as a best practice for nerve location in modern regional anesthesia, and presents an objective analysis of ultrasound and nerve stimulation studies.

Peripheral nerve blocks, which block pain at its source through precise injection of a local anesthetic, are used in an estimated two million procedures each year in North America. Nerve stimulation has long been the “gold standard” for nerve location when performing peripheral nerve blocks, stimulating the nerve and causing the target muscle to twitch. More recently, high-frequency ultrasound imaging has increasingly gained ground as a supplementary or complementary modality as it enables the anesthesiologist to see the nerve and the needle, as well as the spread of local anesthesia.

Nerve stimulation and ultrasound-guided regional anesthesia each offer distinct advantages and limitations. Until now, however, a comprehensive information source for anesthesiologists that provides an objective, clinical review of best practices using both technologies did not exist. 

Focused on the evolution of nerve location, the educational guide cites several key nerve stimulation and ultrasound studies that have influenced the use of nerve stimulation and ultrasound in clinical practice. For more information or to obtain a complimentary copy of the educational guide, please email dualguidance.us@bbraun.com.

 

CDC collaborates on Preventing Skin Infections program with wrestling coaches

The National Wrestling Coaches Association (NWCA) recently announced the release of Preventing Skin Infections, a Web-based seminar that is available for viewing by state high school activity associations, collegiate governing bodies, athletes, parents, certified athletic trainers and other medical personnel. CDC and NWCA collaborated in development of the MRSA topic. The producers also worked with the National Athletic Trainers Association (NATA) and other sports medicine agencies to produce all-sports and sport-specific modules for interactive classroom or one-on-one learning.

Keying in on three classifications of microbes—fungi (ringworm), bacteria (Strep and Staph, including MRSA) and virus (Herpes Gladiatorum). The goal is to help protect student-athletes from these pathogens. The seminar movies make extensive use of animation, special effects, graphics, studio and on-location shooting. The seminar is suitable for all sports with a special module devoted to the issues and procedures germane to wrestling. The presentation is informative, entertaining and educational for anyone in any type of skin contact activities.  Visit here for the presentation

 

Munson Healthcare signs Multi-Suite Lawson Software contract

Lawson Software announced that Munson Healthcare licensed the Lawson Human Resource Management Suite and Lawson Business Intelligence, part of the Lawson S3 Enterprise Performance Management Suite. The healthcare provider will use the Lawson system to consolidate administrative processes and support its integrated human resources and payroll services. The contract was signed during Lawson’s first quarter of fiscal 2009, which ended Aug. 31, 2008.

Munson Healthcare has a medical staff approaching 500 and is affiliated with eight hospitals in northern Michigan, including Munson Medical Center in Traverse City and Paul Oliver Memorial Hospital in Frankfort. The regional health system also consists of an air and ground medical transport service and a home health agency.

Munson Healthcare chose Lawson to support an organization-wide initiative to simplify and modernize its HR processes. The healthcare provider also wanted an HR system that would support its evolving technology and business needs. 

 


October 16, 2008   Download print version

MedAssets launches Medicare RAC solution for hospitals and health systems

Chinese citizens up for debate over healthcare reform

Premier CEO Rick Norling to retire

US rate of infant death worsens to 29th in world

FDA creates web page with drug safety information for patients, healthcare professionals

Hospira acquires Endotool from MD Scientific

Health firms to study clots in stent patients

Goodroe Healthcare Solutions earns first approval from the Inspector General for a multi-year gainsharing project


MedAssets launches Medicare RAC solution for hospitals and health systems

MedAssets, Inc. has announced the release of its Medicare Recovery Audit Contractor (RAC) solution to support healthcare providers’ strategies to address RAC audits. MedAssets’ comprehensive RAC solution assists providers throughout the entire RAC audit process – from assessment to appeal – and provides overall revenue integrity solutions for long-term financial performance improvement. It provides a RAC workflow tool that helps hospitals manage RAC audit timelines and activities, automate deadline notifications, track activity and audit historical claims to identify vulnerabilities. In addition, MedAssets consulting services assess reimbursement risk and its RAC appeal and recovery services help providers manage, defend and appeal RAC audits.  

Beyond reimbursement management, MedAssets’ suite of revenue cycle management solutions include concurrent denial management, claims management, contract management, and web-based data-driven applications that specifically address revenue integrity in the areas of patient estimates, charge capture, and clinical documentation. MedAssets’ end-to-end solutions offer providers a means to close the financial gaps created by RAC audits and other Centers for Medicare and Medicaid Services (CMS) initiatives. Visit www.medassets.com for more information.

 

Chinese citizens up for debate over healthcare reform  

BEIJING -- China's new healthcare reform plan, which aims to provide universal medical service to 1.3 billion people, has triggered nationwide debate since it was publicized on Tuesday morning. News articles on healthcare reform showed up in major newspapers and online forums were swarmed with netizens eager to express their opinion.  

Growing public criticism of soaring medical fees, a lack of access to affordable medical services, poor doctor-patient relationships and low medical insurance coverage compelled the government to launch the new round of reforms. China first started reforming healthcare in 1992 to abolish a system under which the government covered more than 90 percent of expenses. The country then gradually switched to a market-oriented medical system. However, soaring medical costs plunged many rural and urban Chinese into poverty.  

In the new plan, the government promised to set up a "safe, effective, convenient and affordable" healthcare system that would cover all urban and rural residents by 2020. The draft lists five priorities: speeding up the establishment of a universal healthcare system, setting up a basic drug system, improving the grassroots health service network, providing equal public health service to rural and urban residents and pushing forward reform trials in state-run hospitals.  

Healthcare reform debates have been going on in China for years. In 2006, the State Council, the country's Cabinet, set up a joint-working team consisting of experts from 16 departments to create a reform plan. It also entrusted nine domestic and overseas organizations, including the World Health Organization, to conduct independent research.  

"Healthcare reform is a tough problem worldwide," Peking University professor Li Ling said. "To mobilize the whole nation to join the debate is an unprecedented move of the Chinese government, which ensures that the decision could be made in a prudent, scientific and democratic way." (China View) Read the original story.

 

Premier CEO Rick Norling to retire 

Richard A. (Rick) Norling will retire as president and chief executive officer of Premier Inc., the nationwide healthcare alliance, on June 30, 2009, the end of his current contract term. A process is underway to have a successor identified well before then and ensure a smooth transition, said Premier Board Chair Lowell C. Kruse, president and CEO of Heartland Health in St. Joseph, Mo. Norling has been planning for his eventual retirement for some time and the succession planning process allows for orderly transition before he leaves. 

Norling first joined Premier as chief operating officer in 1997, the year after Premier was created through the mergers of three smaller organizations. He became its president and CEO in 1998. Earlier, he was president and chief executive officer of Fairview Hospital and Healthcare System, headquartered in Minneapolis/St. Paul in Minnesota.  

The Premier Board and its committees are engaged in the customary work associated with identifying a successor leader, Kruse reported. An executive search firm, Spencer Stuart, is engaged to assist the board, and, consistent with best-practice principles, external and internal candidates are to be considered. 

 

US rate of infant death worsens to 29th in world

Infant deaths in the United States continue to surpass most other rich nations, stalling at the same level from 2000 through 2005 while other countries improved, government researchers said. Latest international data show the US ranking in infant mortality worsened to 29th worldwide, down from 27th in 2000 and 23rd in 1990, according to a report from the National Center for Health Statistics in Hyattsville, Md.

Researchers attribute the lack of progress in part to greater numbers of premature births, though the report said preliminary results suggested a small drop in US infant deaths from 2005 to 2006.

Infant mortality is one of the most important statistics for researchers assessing the health of nations. Japan, Sweden, Britain, Spain, France, Germany, Australia, and 15 other countries all had infant mortality rates of fewer than 5 deaths for every 1,000 births in 2004, about 26 percent below the US rate of just under seven deaths per 1,000 live births through the last five years for which data are complete, ending in 2005.

An analysis of about 95 percent of US birth records suggests a 2 percent decline in infant mortality in 2006, MacDorman said. The US ranking of 29th puts it even with Poland and Slovakia. Blacks had the highest rate of infant mortality in 2005, at 13.63 deaths per 1,000 live births, or about double the national average. Rates among Puerto Ricans and Native Americans topped eight deaths per 1,000 live births. Read the original story.

 

FDA creates web page with drug safety information for patients, healthcare professionals

Consumers and healthcare professionals can now go to a single page on the U.S. Food and Drug Administration's Web site to find a wide variety of safety information about prescription drugs. The Web page, http://www.fda.gov/cder/drugSafety.htm, provides links to information on: drug-specific safety information and safety sheets; drug labeling and patient package inserts; drugs that have a Risk Evaluation and Mitigation Strategy (REMS) to ensure that their benefits outweigh their risks; a searchable database of postmarket studies with additional information about a drug's safety, efficacy, or optimal use; a searchable database of clinical trials, including information about each trial's purpose, who may participate, locations, and useful phone numbers.

Also included: Warning Letters, Import Alerts, Recalls, Market Withdrawals, and Safety Alerts; Regulations and guidance documents; Instructions how to report problems to the FDA through its MedWatch program.  

Establishing such a web page is one of the requirements of the Food and Drug Administration Amendments Act of 2007, and is among FDA's many efforts to address the safe use of drugs throughout their lifecycle.  

 

Hospira acquires Endotool from MD Scientific

Hospira, Inc. announced yesterday that it has acquired the EndoTool business from MD Scientific, LLC. The EndoTool glucose management system is a FDA approved software system which helps establish and maintain glycemic control in acute, critical care and operating room settings by calculating the dose of intravenous (I.V.) insulin needed to effectively control blood glucose levels.

Traditionally, nurses and other clinicians use paper-based protocols to manually monitor and adjust I.V. insulin dosing. The EndoTool software system is easy to operate, runs on a hospital's existing computer system and can interface with a hospital information system (HIS). EndoTool actively models and adapts to individual patient responses to I.V. insulin to help manage current and predict future dosage levels. It is the only software that uses five separate data points -- based on the patient's most recent blood glucose readings -- to provide personalized, safe and effective glycemic control.  

As part of the agreement, Hospira acquired additional assets related to the EndoTool business, including the MD Scientific headquarters in Charlotte, N. C., and the employees supporting the product. Financial details of the agreement were not disclosed. www.hospira.com

 

Health firms to study clots in stent patients  

In an unusual display of collaboration, eight medical companies are joining forces to launch a $100 million study to determine how best to protect heart patients from rare but dangerous clots after they are treated with artery-opening devices called stents. The four-year, 20,000-patient study is intended to determine whether stent patients can safely go off aggressive blood-thinning treatment after one year, or if they'd be better to remain on the medication for at least 2˝ years after getting a stent.

Current guidelines call for patients who get a drug-coated stent to remain on the medicine for at least a year. But concern that, in rare instances, clots can form in the devices well over a year after they are implanted, with potentially lethal consequences, has left doctors and patients in a quandary over how long treatment should be prescribed.

Four of the companies are stent makers Boston Scientific Corp., Johnson & Johnson, Medtronic Inc. and Abbott Laboratories Inc. The companies are fierce rivals in the $5 billion global market for the devices. Four drug companies are also participating. Bristol-Myers Squibb Co. and Sanofi Aventis SA co-market the antiplatelet drug Plavix, which combined with aspirin makes up the current regimen for most stent patients. They are bracing for competition from Eli Lilly & Co. and Daiichi Sankyo of Japan, which are co-developing prasugrel, which is awaiting FDA approval.

The study is the result of an FDA request for stent and drug makers to determine the optimal duration for blood thinning. Separately at the heart meeting, a Boston Scientific-sponsored study suggested that heart-attack victims fare better with drug-coated stents instead of older bare-metal models. Wednesday's study found coated stents reduced the need for repeat procedures within a year to 4.5% from 7.5%. It didn't find a difference between the two stents' safety. Read the original story,

 

Goodroe Healthcare Solutions earns first approval from the Inspector General for a multi-year gainsharing project

Goodroe Healthcare Solutions, LLC, a VHA company, announced that the U.S. Department of Health and Human Services' Office of the Inspector General (OIG) has approved a three-year gainsharing project for cardiovascular procedures. This is Goodroe's first approval for a multi-year project and its twelfth OIG approval.  

Gainsharing allows hospitals to share cost savings with participating physicians who achieve operational efficiencies. Currently, Goodroe's gainsharing model is used in clinical areas where physicians control the majority of costs, such as cardiac catheterization procedures, open heart surgery and orthopedic and spine procedures.  

While arrangements with individual hospitals vary, most allow participating physicians to be paid as much as 50 percent of the savings generated through increased hospital and physician collaboration to decrease overall costs while demonstrating quality patient outcomes. Goodroe has used its approved gainsharing methodology to identify nearly $75 million in savings for hospitals while ensuring the best quality of care for patients.  

Goodroe's gainsharing model is based on documented patient information collected by Goodroe's proprietary software and database while the patient is receiving care. Visit www.goodroe.com for more information.

 


October 15, 2008   Download print version

Broadlane to manage procurement and materials management at Tenet Healthcare Corporation’s 52 hospitals

GAO report: Variation in standards and guidance limits comparison of how nonprofit hospitals meet community benefit requirements

3M RAC ready program helps hospitals identify compliance risks, prepare for RAC audits

LSU Health Care Services selects IntelliDOT as its barcode point-of-care partner

Johnson & Johnson posts strong results

World Health Report calls for return to primary healthcare approach

Hospitals protest new California rules on patient billing

Kimberly-Clark Health Care adds two-hour option to oral care kit portfolio
 


Broadlane to manage procurement and materials management at Tenet Healthcare Corporation’s 52 hospitals

Broadlane has announced that Tenet Healthcare Corporation (THC) in Dallas, TX, has outsourced its materials management and procurement functions for its 52 hospitals. In September, Tenet signed a seven-year agreement with Broadlane to manage its approximate $1.5 billion in annual spend. Beginning January 1, 2009 and continuing through early 2010, Tenet’s approximately 200 materials management and procurement employees will become Broadlane employees.

With the addition of Tenet Healthcare, Broadlane will provide outsourced supply chain management services to 110 acute care hospitals, manage more than $4 billion in annual supply spend and employ 375 outsourced supply chain management specialists.

Broadlane will provide national GPO portfolio management, regional GPO portfolio management and custom agreements for Tenet. In addition, Broadlane will assume day-to-day responsibility for receiving and internal product distribution, inventory management and Value Analysis Teams (VAT) management. Tenet will continue to utilize Broadlane Informatics for access to reports and to improve insight related to contracts, capital equipment, pharmacy and other key areas of spend management. 

In addition to all materials and inventory management functions, Broadlane will support Tenet with Procurement Services, supporting the purchasing processes related to supply chain products, consumable goods, purchased services and capital equipment and manage Tenet’s item master. Broadlane’s Item Master Services, also part of Procurement Services, will manage processes and data related to Tenet’s item master. For more visit www.broadlane.com


 

GAO report: Variation in standards and guidance limits comparison of how nonprofit hospitals meet community benefit requirements

Nonprofit hospitals qualify for federal tax exemption from the Internal Revenue Service (IRS) if they meet certain requirements. Since 1969, IRS has not specified that these hospitals have to provide charity care to meet these requirements, so long as they engage in activities that benefit the community. Many of these activities are intended to benefit the approximately 47 million uninsured individuals in the United States who need financial and other help to obtain medical care.

Previous studies indicated that nonprofit hospitals may not be defining community benefit in a consistent and transparent manner that would enable policymakers to hold them accountable for providing benefits commensurate with their tax-exempt status. IRS’s community benefit standard allows nonprofit hospitals broad latitude to determine the services and activities that constitute community benefit. Furthermore, state community benefit requirements that hospitals must meet in order to qualify for state tax-exempt or nonprofit status vary substantially in scope and detail.

GAO found that among the standards and guidance used by nonprofit hospitals, consensus exists to define charity care, the unreimbursed cost of means-tested government healthcare programs (programs for which eligibility is based on financial need, such as Medicaid), and many other activities that benefit the community as community benefit. However, consensus does not exist to define bad debt (the amount that the patient is expected to, but does not, pay) and the unreimbursed cost of Medicare (the difference between a hospital’s costs and its payment from Medicare) as community benefit. Variations in the activities nonprofit hospitals define as community benefit lead to substantial differences in the amount of community benefits they report.

With the added attention to community benefit has come a growing realization of the extent of variability among stakeholders in what should count and how to measure it. At present, determination and measurement of activities as community benefit for federal purposes are still largely a matter of individual hospital discretion. Given the large number of uninsured individuals, and the critical role of hospitals in caring for them, it is important that federal and state policymakers and industry groups continue their discussion addressing the variability in defining and measuring community benefit activities. Click here.

 

3M RAC ready program helps hospitals identify compliance risks, prepare for RAC audits

3M Health Information Systems has introduced the 3M RAC Ready Program, a new solution that combines expert consulting with advanced software to help hospitals prepare for increased compliance scrutiny under the federal government's Recovery Audit Contractor (RAC) program. The program provides comprehensive tools and services to identify areas of risk, reduce audit vulnerability, and promote fast and efficient responses to RAC activities.

Mandated by Congress and administered by the Centers for Medicare and Medicaid Services (CMS), the RACs seek to identify improper Medicare payments through in-depth auditing of hospitals, physicians, and suppliers that submit claims to the Medicare Fee-for-Service program.

The 3M RAC Ready Program builds on the foundation of the 3M Coding and Reimbursement System, which promotes accurate, complete and compliant coding. Core components include 3M Validation and Appeal Services for Recovery Audit Contractors (RACs), a complete baseline assessment that determines a hospital's exposure under the RAC program. 3M consultants work onsite with clients to target areas of risk, focusing on coding, medical necessity and documentation to improve claims accuracy and reduce denials.

The 3M Audit Expert System works in conjunction with the 3M Coding and Reimbursement System to review 100 percent of inpatient records for compliance errors at the point of coding, and offers customized coding alerts, retrospective auditing tools, and trending reports that allow comparisons with national norms. The software features a RAC tracking and management tool that streamlines workflow by tracking RAC communications, denials and related appeals, monies recovered, and areas of risk. For more information visit here


 

LSU Health Care Services selects IntelliDOT as its barcode point-of-care partner

IntelliDOT Corporation, a provider of wireless handheld, barcode point-of-care (BPOC) solutions to hospitals, announced that the Louisiana State University Health Care Services Division (LSUHCSD) has selected IntelliDOT Bedside Medication Administration, Vital Signs Collection and Mother-Baby Breast Milk Matching modules as part of an enhanced patient safety initiative. LSUHCSD is a division of the Louisiana State University Health System, Baton Rouge, LA and consists of seven hospitals with 704 beds and 300 outpatient clinics that serve the underprivileged and uninsured in Louisiana. LSUHCSD is one of the largest public hospital systems in the United States.

The IntelliDOT Bedside Medication Administration prompts the nurse through medication administration workflows at the bedside. The system is used to verify the five rights of medication administration: right medication, right dose, right route, right patient, and right time. Each nurse receives customized prompts and warnings to assure medications are administered and documented correctly.

IntelliDOT Mother-Baby Breast Milk Matching – Using the same handheld device and a small portable wireless printer, a nurse prints barcode labels for milk containers at the time milk is received from the mother or the mother can take and apply the labels at home. At administration, the infant’s ID band is scanned along with the breast milk container, assuring positive identification and accurate feeding.

IntelliDOT Vital Signs Collection – Vital signs information plus virtually any clinical documentation can be captured using the same handheld device. The captured data can populate the eMAR or electronic flow sheets and/or print on separate patient-specific flow sheets. For more information visit here.

 


Johnson & Johnson posts strong results

Johnson & Johnson showed resilience Tuesday in the face of an economic downturn, posting higher third-quarter sales and earnings. Because the large medical products company is more broadly diversified than many other drug and medical device makers, Johnson & Johnson’s report is not necessarily considered a bellwether for the entire healthcare industry. Hospitals, for example, tend to be retrenching, squeezed by the credit crisis and concerns about patients’ ability to pay their bills.

But healthcare products, like the artificial joints made by Johnson & Johnson’s DePuy division, may be less subject to the economic winds buffeting most sectors of the economy.

“Everything we’ve seen so far has shown that healthcare has been pretty defensive and volumes have not been affected by the downturn in the economy,” said David H. Roman, a medical devices analyst for Morgan Stanley.

For example, up to 70 percent of hip and knee replacements, a large part of the medical device industry, are performed on Medicare beneficiaries — a group whose insurance coverage is guaranteed and who would be unlikely to delay surgery because of the economy. And, as Roman said, Medicare beneficiaries are growing in numbers.

Another medical products company, Abbott, is set to announce its earnings Wednesday morning. Many analysts predict those numbers will also be strong, largely because of the company’s Xience drug-coated heart stent, a device that has become popular among interventional cardiologists, Roman said. Xience’s success is coming in part at the expense of Johnson & Johnson’s Cypher stent, which is one of the rare devices in the company’s portfolio that did not show solid growth.

In Johnson & Johnson’s earnings call with analysts on Tuesday, Dominic Caruso, the chief financial officer, said that the company’s access to commercial paper had been unfettered and available at what he called “very, very good” rates. That could bode well for other health products company.

Johnson & Johnson announced sales of $15.9 billion for the third quarter, up 6.4 percent from a year earlier. Excluding special charges, the company said it earned $1.17 a share in the third quarter, versus 88 cents a year earlier. (NY Times) Visit here for the complete story.


 

World Health Report calls for return to primary healthcare approach

The World Health Report 2008 critically assesses the way that healthcare is organized, financed, and delivered in rich and poor countries around the world. The WHO report documents a number of failures and shortcomings that have left the health status of different populations, both within and between countries, dangerously out of balance. The report, titled PrimaryHealth Care – now more than ever, commemorates the 30th anniversary of the Alma-Ata International Conference held in 1978. That event was the first to put health equity on the international political agenda.

In a wide-ranging review, the new report found striking inequities in health outcomes, in access to care, and in what people have to pay for care. Differences in life expectancy between the richest and poorest countries now exceed 40 years. Of the estimated 136 million women who will give birth this year, around 58 million will receive no medical assistance whatsoever during childbirth and the postpartum period, endangering their lives and that of their infants.

Globally, annual government expenditure on health varies from as little as US$ 20 per person to well over US$ 6000. For 5.6 billion people in low- and middle-income countries, more than half of all healthcare expenditure is through out-of-pocket payments. With the costs of healthcare rising and systems for financial protection in disarray, personal expenditures on health now push more than 100 million people below the poverty line each year.

Data set out in the report are indicative of a situation in which many health systems have lost their focus on fair access to care, their ability to invest resources wisely, and their capacity to meet the needs and expectations of people, especially in impoverished and marginalized groups. As the report notes, conditions of “inequitable access, impoverishing costs, and erosion of trust in healthcare constitute a threat to social stability.”

To steer health systems towards better performance, the report calls for a return to primary healthcare, a holistic approach to healthcare formally launched 30 years ago. When countries at the same level of economic development are compared, those where healthcare is organized around the tenets of primary healthcare produce a higher level of heath for the same investment.

In far too many cases, people who are well-off and generally healthier have the best access to the best care, while the poor are left to fend for themselves. Healthcare is often delivered according to a model that concentrates on diseases, high technology, and specialist care, with health viewed as a product of biomedical interventions and the power of prevention largely ignored. WHO estimates that better use of existing preventive measures could reduce the global burden of disease by as much as 70%. Visit here for the complete summary.


 

Hospitals protest new California rules on patient billing

California emergency room patients can no longer be stuck with the bill when hospitals or physicians disagree with insurance companies on their fees. Under new state rules that take effect today, hospitals and physicians are barred from billing patients for the balance of emergency care not covered by insurers. But the relief for patients may not last long. Hospitals and physicians are protesting the rules in court. Meanwhile, the state Supreme Court is set to hear another "balance billing" challenge next month.

In another court test set for hearing this month, the state Department of Managed Health Care sued Prime Healthcare Services Inc. of Victorville. The state is seeking to bar Prime from billing insured patients for unpaid medical bills that the hospital chain contends it is owed from insurers and is seeking from patients as a last resort.

Department director Cindy Ehnes, called Prime a "serial balance biller whose actions have unjustly threatened the credit rating of thousands of Californians." Ehnes said she wanted to take patients out of the middle of billing disputes between insurers, hospitals and physicians.

"No longer will Californians face the possibility that if they have to use an emergency room, they may be stuck with a bill, asking them to pay a second time for emergency care, which they already purchased with their [insurance] policy," she said. The disputes typically occur when an insured patient ends up in an emergency room that is not in his or her carrier's network.

These hospitals and physicians may send insurers bills that are higher than what the insurance firms usually pay providers in their network. And insurers often balk, sending back less than the full payment. Insurers accuse hospitals and physicians of taking advantage of the situation and sending out inflated bills. Hospitals and physicians counter that it is the insurers that take advantage by paying far less than reasonable and customary rates. Patients wind up in the middle of such disputes when a hospital or physician bills them for the balance.

The department also announced that it would address what Ehnes called "the root cause of balance billing", the unfair or late payment of legitimate emergency room claims by insurers. She said the department would add resources to speed up the resolution of hospital and physician complaints over such practices.
 
Prime Healthcare lawyer Michael Sarrao said the new rules favored insurers and hurt doctors and hospitals. Sarrao said hospitals had no idea what they would get paid by insurers with which they had no contracts. One of Prime's hospitals in Chino, for example, treated two children for coyote bites within three months. In the first case, the insurer paid about 90% of billed charges. In the second, the same insurer paid less than 40%. (LA Times) Visit here for the complete story.


 

Kimberly-Clark Health Care adds two-hour option to oral care kit portfolio

Kimberly-Clark Health Care announced today that as part of its ongoing commitment to providing clinicians with a range of effective clinical solutions and best practice education to address Ventilator-Associated Pneumonia (VAP), it has added the KimVent Oral Care q2 Kit to its portfolio of oral care solutions. Now, caregivers will have the ability to administer oral hygiene care every two hours to ventilator-dependent patients at risk for VAP.

A leader in developing clinical solutions against healthcare-associated infections, Kimberly-Clark Health Care introduced the KimVent Oral Care q4 Kit in October 2007. With the addition of the new KimVent Oral Care q2 Kit, along with individual components and packs, Kimberly-Clark Health Care now allows caregivers the flexibility to choose from a portfolio of oral care solutions. The KimVent Oral Care portfolio is designed to provide comprehensive oral care for individual patient needs as well as q2 and q4 hospital oral care protocols, helping to meet clinical recommendations from organizations such as the Centers for Disease Control and Prevention and the American Association for Critical Care Nurses for an oral hygiene program for at-risk patients.

The new KimVent Oral Care q2 Kit includes all components of the original q4 Kit, but also contains extra features for more frequent oral care administration. Unique to the q2 Kit are six additional suction swab packs with alcohol-free mouthwash and a color-coded “Order of Use Guide.” The guide provides nurses with easy identification of component packs and step-by-step visual instructions to promote proper continuity of care and compliance as well as support both individual patient needs and hospital oral care protocol.

Designed by nurses, for nurses to address the challenges associated with oral care products, the KimVent Oral Care q4 and q2 products incorporate a convenient and portable design as well as ergonomic and user-friendly tools. Both kits can be kept at the patient’s bedside and contain individual procedure packs that allow nurses to choose the appropriate tools easily. For more information visit http://www.kchealthcare.com/kimvent.


 


October 14, 2008   Download print version

Serotype 19A infection eludes a leading children’s vaccine

Cancer screening rates among older Medicaid patients fall short of national objectives

Intensive support programs can help hospitalized smokers stay smoke-free

HealthGrades annual hospital quality study shows death rate 70 percent lower at top-rated hospitals

Researchers discover baldness gene: 1 in 7 men at risk

How workable are the presidential candidates' health reform plans?

Vitamin D a key player in overall health of several body organs and Parkinsons Disease

Doctors double vitamin D for children
 


Serotype 19A infection eludes a leading children’s vaccine

A highly drug-resistant germ has become a common cause of meningitis, pneumonia and other life-threatening conditions in young children. The culprit — a strain of strep bacteria — can conquer almost all antibiotics in pediatrics, and has dodged a vaccine otherwise credited with causing the number of serious infections in children to plummet.

Since 2000, American toddlers have been immunized against Streptococcus pneumoniae, or pneumococcus, an organism that preys largely on children younger than 5 and the elderly. Pneumococcal meningitis can be fatal, and survivors are often left with deafness and other lifelong neurological problems. By most measures, the vaccine has worked: by 2002, rates of infection from these bacteria had dropped as much as 80 percent in some places. But progress has now stalled, and infection with a particular type of pneumococcus, Serotype 19A, is steadily rising.

“It’s very much a concern,” said Bernard Beall, a pneumococcal expert at the federal Centers for Disease Control and Prevention. Last year, in The Journal of the American Medical Association, pediatricians described an outbreak of Serotype 19A ear infections in Rochester that could be cured only by surgically implanting tubes, or by turning to adult medicines not yet tested for safety in children.

A greater worry, however, is the frequency of meningitis, pneumonia and bloodstream infections from Serotype 19A. Since 2001, rates of these and other invasive pneumococcal diseases have crept upward, to more than 10 per 100,000 children from about 2 per 100,000. A fourfold increase in life-threatening infections has also occurred among the elderly.

The vaccine Prevnar is aimed at seven types of bacteria that were responsible for 70 to 80 percent of pneumococcal illness during the 1990s. Because pneumococci come in 91 forms, experts have worried from the start whether bacteria that were just as deadly, but not wiped out by the vaccine, might move in as opportunists when the competition suddenly vanished.

The bacteria live in the nose and throat, usually as microbial freeloaders of no consequence. Occasionally — often after a simple viral infection — pneumococci slip into inner areas of the body and cause disease. Weaker immune systems in the very young and the very old leave them most vulnerable. The pneumonia shot in older people includes 19A. Not all of the 91 incarnations of pneumococcal bacteria are dangerous. The variation in genes slightly alters how the bacteria function and how they are received by the immune system.

For vaccine manufacturers, pneumococci’s diversity presented a challenge: how to teach the immune system to recognize a target that may look a little different from child to child. Serotype 19A was around in the 1990s, though uncommon, and the vaccine includes a similar version called 19F. The hope in 2000 was that 19F looked enough like 19A to set off an immune reaction. It did not.  

The vaccine’s manufacturer, Wyeth, says it has been working quickly to develop a new product to counter 19A and five other pneumococcal variations, along with the original seven. The company will release results of the first large studies of the newer version this month at an infectious disease meeting in Washington. (NY Times) Visit here for the complete story.


 

Cancer screening rates among older Medicaid patients fall short of national objectives

Only about half of Medicaid recipients age 50 and older appear to receive recommended screening tests for colorectal, breast and cervical cancer, according to a report in the October 13 issue of Archives of Internal Medicine. These three types of cancer are potentially curable when detected early, and eliminating disparities in screenings is part of the government's Healthy People 2010 plan. "State Medicaid agencies are in a unique position to monitor and improve the quality of care received by some of the nation's most vulnerable citizens," the authors write.

"Documentation that colorectal, breast and cervical cancer screening was recommended by the primary care provider was found for only 52.7 percent, 60.4 percent and 51.5 percent of eligible patients, respectively," the authors write.

"Documented rates of adequate screening were 28.2 percent for colorectal cancer, 31.7 percent for mammography within two years and 31.6 percent for Papanicolaou [cervical cancer] test within three years. When medical record and claims data were combined, approximately half of eligible patients had evidence of screening."

Despite Medicaid recipients' access to primary care and full coverage of cancer screening services, these rates are substantially lower than those in the general population, the authors note. "Lack of a screening recommendation by the physician, rather than patient refusal of recommended tests, accounted for most instances of screening delinquency," they conclude. "Efforts to increase cancer screening rates among Medicaid recipients must address patient, physician and organizational barriers to the routine identification and delivery of preventive services."


 

Intensive support programs can help hospitalized smokers stay smoke-free

Hospital-sponsored stop-smoking programs for inpatients that include follow-up counseling for longer than one month significantly improve patients' ability to stay smoke-free. An analysis of clinical trials of programs offered at hospitals around the world finds that efforts featuring long-term support can increase participant's chances of success by 65 percent. The study – led Nancy Rigotti, MD, director of the Tobacco Research and Treatment Center at Massachusetts General Hospital (MGH) – appears in the October 13 Archives of Internal Medicine and is one of several articles focused on smoking.

"While nobody looks forward to a hospital stay, it can really have an extra benefit for smokers" said Rigotti. "But this is only if the hospital helps them quit with counseling during and after their hospital stay. Hospitals really need to step up to the plate and offer this type of service routinely, and it also should be reimbursed by payors."

Analyzing hospital-based efforts according to their intensity – a single brief smoking-related contact, one or more extended contacts during hospitalization, hospital contact plus a month or less of post-discharge telephone support, and hospital contact followed by more than a month of post-discharge support – revealed that only programs with the highest intensity level were more successful than usual care in helping patients quit for six months or longer.

Although the success rate for patients admitted with cardiovascular disease was a bit higher, intensive counseling was successful for all hospitalized smokers, regardless of their diagnosis.

The program offered at MGH begins by automatically flagging patients' smoking status upon admission and giving each patient who smokes a booklet addressing how to use their stay to help them quit smoking. Dedicated smoking-cessation counselors visit with patients during their hospitalization and call them after discharge to check on their progress and offer further assistance. Because of this program and other stop-smoking efforts, the hospital increased its JCAHO/CMS smoking measure score to 100 percent.


 

HealthGrades annual hospital quality study shows death rate 70 percent lower at top-rated hospitals

Patients have on average a 70 percent lower chance of dying at the nation's top-rated hospitals compared with the lowest-rated hospitals across 17 procedures and conditions analyzed in the eleventh annual HealthGrades Hospital Quality in America Study, issued today. While overall death rates declined from 2005 to 2007, the nation's best-performing hospitals were able to reduce their death rates at a much faster rate than poorly performing hospitals, resulting in large state, regional and hospital-to-hospital variations in the quality of patient care, the study found.

HealthGrades Hospital Quality in America study also found that if all hospitals performed at the level of five-star rated hospitals, 237,420 Medicare deaths could potentially have been prevented over the three years studied. More than half of those deaths were associated with four conditions: sepsis, pneumonia, heart failure and respiratory failure.

Full reports on death rate trends in each of the 50 states and the District of Columbia are available in the study. And, for the first time, HealthGrades has released hospital death rates for the nation's 15 largest metropolitan statistical areas. Large variation exists between major metropolitan areas.

Large gaps persist between the "best" and the "worst" hospitals across all procedures and diagnoses studied. Five star-rated hospitals had significantly lower risk-adjusted mortality across all three years studied. Across all procedures and diagnoses studied, there was an approximate 70 percent lower chance of dying in a 5-star rated hospital compared to a 1-star rated hospital. Across all procedures and diagnoses studied, there was an approximate 50 percent lower chance of dying in a 5-star rated hospital compared to the U.S. hospital average.

The full study and state-by-state hospital-quality statistics can be found at www.healthgrades.com.


 

Researchers discover baldness gene: 1 in 7 men at risk

Researchers at McGill University, King's College London and GlaxoSmithKline Inc. have identified two genetic variants in caucasians that together produce an astounding sevenfold increase the risk of male pattern baldness. Their results were published Oct. 12 in the journal Nature Genetics.

About a third of all men are affected by male pattern baldness by age 45. The condition's social and economic impact is considerable: expenditures for hair transplantation in the United States alone exceeded $115 million (U.S.) in 2007, while global revenues for medical therapy for male-pattern baldness recently surpassed $405 million. Male pattern baldness is the most common form of baldness, where hair is lost in a well-defined pattern beginning above both temples, and results in a distinctive M-shaped hairline. Estimates suggest more than 80 percent of cases are hereditary.

The researchers conducted a genome-wide association study of 1,125 caucasian men who had been assessed for male pattern baldness. Researchers have long been aware of a genetic variant on the X chromosome that was linked to male pattern baldness, said Dr. Brent Richards of McGill University's Faculty of Medicine and the affiliated Jewish General Hospital. "That's where the idea that baldness is inherited from the mother's side of the family comes from," he explained. "However it's been long recognized that that there must be several genes causing male pattern baldness. Until now, no one could identify those other genes. If you have both the risk variants we discovered on chromosome 20 and the unrelated known variant on the X chromosome, your risk of becoming bald increases sevenfold."

"What's startling is that one in seven men have both of those risk variants. That's 14 percent of the total population!"


 

How workable are the presidential candidates' health reform plans?

John McCain and Barack Obama's health reform plans are different both in their approaches to solving problems and their potential effects on voters. But to choose wisely, you have to do some homework. To help, the Los Angeles Times offers a guide to online resources that analyze how well the candidates' proposals might work.

Here's a summary of their proposals and a list of online resources for more information from the Times.

John McCain would…

- Eliminate current tax exclusion for employer-paid health insurance.
- Provide refundable tax credits of $2,500 for individuals or $5,000 for families, for everyone who obtains private health insurance – employee or not. If insurance costs less than the value of the credit, the remaining funds could be deposited in a health savings account.
- Provide a variety of insurance choices, national and across state lines, that would not be dependent on a job.
- Work with state governors to increase insurance pools for people uninsurable on the individual market.

- Deregulate insurance markets, allowing insurers to sell across state lines. People could buy less costly, less comprehensive policies in states with fewer mandates.
- Pass medical malpractice reform.
For more details, see McCain's full healthcare plan.

Barack Obama would…

- Require employers (some small businesses would be exempt or subsidized) to either offer health insurance to employees or pay a tax that would be used to help uninsured people get insurance.
- Provide subsidies for low-income Americans to help them afford coverage.
- Create a new national health plan, similar to Medicare, for the uninsured and small businesses.
- Require that all children have health insurance.
- Regulate private insurance plans to end risk-rating based on health status – a system that can render people like cancer survivors or diabetes patients uninsurable.
- Establish a federal reinsurance program to protect businesses against the costs of workers' expensive medical episodes.

For more, details see Obama's full healthcare plan.

The United States spent $2.1 trillion on healthcare in 2006, according to national health expenditure data from the Centers for Medicare and Medicaid Services. That number is expected to hit $4.3 trillion by the end of 2017 – 19.5% of the gross domestic product.

The percentage of people with employer-based health insurance fell from 70% in 1987 to 59% in 2006, according to the National Coalition on Health Care. Enrollment in high-deductible health plans with savings options rose from 5% in 2007 to 8% in 2008, according to the Employer Health Benefits 2008 Annual Survey. More than 42 million U.S. residents, or 14% of the population, lack insurance, according to the most recent National Health Interview Survey.

Healthcare ranks third among worries on the minds of registered voters, after the economy and Iraq, according to an October Kaiser Family Foundation poll. By party affiliation, it remains third among Democrats, but Republican voters put it at worry No. 6, after the economy, gas prices, Iraq, terrorism and taxes. (LA Times) Visit here for the complete story.


 

Vitamin D a key player in overall health of several body organs and Parkinsons Disease

Essential for life in higher animals, vitamin D, once linked to only bone diseases such as rickets and osteoporosis, is now recognized as a major player in contributing to overall human health, emphasizes UC Riverside's Anthony Norman, an international expert on vitamin D. In a paper published in the August issue of the American Journal of Clinical Nutrition, Norman identifies vitamin D's potential for contributions to good health in the adaptive and innate immune systems, the secretion and regulation of insulin by the pancreas, the heart and blood pressure regulation, muscle strength and brain activity. In addition, access to adequate amounts of vitamin D is believed to be beneficial towards reducing the risk of cancer.

Norman also lists 36 organ tissues in the body whose cells respond biologically to vitamin D, including bone marrow, breast, colon, intestine, kidney, lung, prostate, retina, skin, stomach and the uterus. According to Norman, deficiency of vitamin D can impact all 36 organs.

Vitamin D is synthesized in the body in a series of steps. First, sunlight's ultraviolet rays act on a precursor compound in skin. When skin is exposed to sunlight, a sterol present in dermal tissue is converted to vitamin D, which, in turn, is metabolized in the liver and kidneys to form a hormone. Norman's laboratory discovered, in 1967, that vitamin D is converted into a steroid hormone by the body.

The recommended daily intake of vitamin D is 200 international units (IU) for people up to 50 years old; 400 IU for people 51 to 70 years old and 600 IU for people over 70 years old. Norman's recommendation for all adults is to have an average daily intake of at least 2,000 IU. About half of the elderly in North America and two-thirds of the rest of the world are not getting enough vitamin D to maintain healthy bone density, lower their risks for fracture and improve tooth attachment.

"There needs to be a sea change by various governmental agencies in terms of the advice they present to citizens about how much vitamin D should be taken," Norman said. "The tendencies of people to live in cities where tall buildings block adequate sunlight from reaching the ground, to spend most of their time indoors, to use synthetic sunscreens that block ultraviolet rays, and to live in geographical regions of the world that do not receive adequate sunlight all contribute to the inability of the skin to biosynthesize sufficient amounts of vitamin D."

In another study from Emory University School of Medicine, a majority of Parkinson's disease patients had insufficient levels of vitamin D. The fraction of Parkinson's patients with vitamin D insufficiency, 55 percent, was significantly more than patients with Alzheimer's disease (41 percent) or healthy elderly people (36 percent). The results are published in the October issue of Archives of Neurology.


 

Doctors double vitamin D for children

The American Academy of Pediatrics is set to announce it is doubling the amount of vitamin D it recommends for infants, children, and adolescents to 400 IU a day, beginning in the first few days of life.

"I don't know of another vitamin that has effects on multiple tissues like vitamin D," said vitamin D researcher Dr. Catherine Gordon, director of the bone health program at Children's Hospital Boston. "As pediatricians, we're still doing research on health outcomes, (and) the relation between vitamin D deficiency during childhood or adolescence and outcomes later in life like osteoporosis, cancer risk, and risk of developing multiple sclerosis. But there are compelling data in adults suggesting an association."

That growing awareness, along with the historical precedence of safely giving 400 IU per day to children, prompted the American Academy of Pediatrics to change its vitamin D recommendation. Even the new 400 international units dose is "a very conservative recommendation" to prevent rickets and vitamin D deficiency in all children, said Dr. Carol Wagner, a pediatrician at the Medical University of South Carolina and a member of the American Academy of Pediatrics Section on Breast-feeding Executive Committee.

Earlier this year, researchers at Children's Hospital Boston found "suboptimal" levels of vitamin D in 40 percent of 380 otherwise healthy infants and toddlers, with 12 percent considered to be clinically deficient. Breast-fed infants were up to 10 times more likely to be deficient in vitamin D than their formula-fed counterparts, according to the study published in the Archives of Pediatrics and Adolescent Medicine.

Today, vitamin D deficiency is rampant because we're coated in sunscreen – in order to avoid skin cancer – or not outdoors enough to soak up the right amount, doctors say. But they aren't recommending sunbathing or tanning beds because they can't determine a safe amount of sunlight exposure to synthesize vitamin D in a given individual. In individuals, vitamin D status differs by distance from the equator and race, with residents of the Northeast and people with more skin pigmentation being at increased risk of deficiency. (Boston Globe) Visit here for the complete story.


 

 


October 13, 2008   Download print version

FDA and PATH malaria vaccine initiative announce research collaboration

Family blames soldier's suicide on anti-malaria drug

Major study of opiate use in children's hospitals provides simple steps to alleviate harm

CRC screening before Medicare age could save millions in federal healthcare dollars

Factors other than antibiotics may raise risk of C. difficile infection: study

Catholic Healthcare West posts stable financial performance in 2008

Study reveals that signs of heart disease are attributed to stress more frequently in women than men

Reminder for nominations: HPN to recognize "Supply Chain-Focused CEOs" in January 2009 edition
 


FDA and PATH malaria vaccine initiative announce research collaboration

The U.S. Food and Drug Administration has announced a collaboration with the PATH Malaria Vaccine Initiative (PATH-MVI) to develop laboratory tests to better predict the level of safety and effectiveness of experimental malaria vaccines before they are used in human clinical trials.

PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions to improve global health and well-being. PATH-MVI supports the development of malaria vaccines and is expected to spearhead the efforts to ensure their availability and accessibility in the developing world once a safe and effective vaccine becomes available.

The PATH-MVI collaborative project is expected to span about three years and is being conducted under the Cooperative Research and Development Agreement (CRADA) program, which allows federal laboratories and businesses to form partnerships that help expedite research activities. Recent scientific advances suggest that vaccines based on live, weakened (attenuated) malaria parasites may be possible in the future but assessing safety and effectiveness in the early stages of product development is challenging. Under this CRADA, PATH-MVI provides the FDA with about $1.5 million to develop tests for evaluating malaria vaccines early in their development.

To date, there are no approved vaccines to prevent malaria but several vaccines are in development. This CRADA will help develop laboratory tests to assess whether a vaccine candidate is safe enough to begin Phase I clinical trials.

The Critical Path Initiative is the FDA's effort to stimulate and facilitate a national effort to modernize the sciences through which FDA-regulated products are developed, evaluated and manufactured.


 

Family blames soldier's suicide on anti-malaria drug

Juan Torres didn't believe that his son, Army Reservist Juan "John" M. Torres, had killed himself in Afghanistan just weeks before he was to return home in July 2004. He figured that John, 25, was murdered because of his opposition to the reportedly rampant heroin trade around the base. So Torres, an Argentine immigrant who works in the Chicago suburbs, launched his own investigation. Now, he is convinced that his son did indeed kill himself. But he blames Lariam, a drug taken by tourists, Peace Corps volunteers and troops to prevent malaria.

An Army psychiatrist's report also suggests the medication was a factor in Torres's suicide. Controversy swirled around Lariam in 2004 after a UPI-CNN investigation linked it to the suicides of six Special Forces soldiers, including three murder-suicides at North Carolina's Fort Bragg in the summer of 2002. Lariam is known to have serious neurological and physical side effects, especially in users who have certain mental health problems. The group Lariam Action USA has catalogued numerous complaints from veterans and others who say they suffered lasting psychological and physical side effects, which sometimes didn't surface until years later.

The Food and Drug Administration's website warns of anxiety, hallucinations and other side effects, and says: "Some patients taking Lariam think about killing themselves, and there have been rare reports of suicides. We do not know if Lariam was responsible for these suicides."

The Pentagon launched an investigation into the drug in 2004, but it is still regularly prescribed for troops in Afghanistan, Iraq and other regions. A study published in the Feb. 11 issue of the peer-reviewed Malaria Journal indicated that almost 10 percent of soldiers sent to Afghanistan have health problems such as depression and bipolar disorder that put them at risk for adverse reactions to the drug. An Army doctor who spoke on the condition of anonymity because he doesn't have permission to speak publicly said he was "floored" to discover while deployed in Afghanistan this year that many troops who were on antidepressant drugs were also prescribed Lariam.

"Not only was this unit misprescribed Lariam, this was being done with the tacit approval of the command," the doctor said. "If a doctor is concerned enough to prescribe an antidepressant, that would indicate they have a problem which would indicate they should not use Lariam. Anecdotally, almost everyone reports some side effects – strange dreams, et cetera – it’s highly likely our folks are experiencing on a daily basis problems related to this drug."

There are two FDA-approved alternate malaria prophylactic drugs, but Lariam is usually preferred by the military because it is taken only once a week. The others are taken daily. (Washington Post) Visit here for the complete story

 


Major study of opiate use in children's hospitals provides simple steps to alleviate harm

Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates. The medications block pain, but they can have nasty side effects. Constipation, for instance, is one side effect that can cause discomfort ­ and even extend a child's hospital stay.

Paul Sharek, MD, MPH, medical director for quality management and chief clinical patient safety officer at Lucile Packard Children's Hospital at Stanford, is the primary author of a new study, detailing the first large multicenter trial in children to show a decrease in harm from pain medications. It shows how simple changes to hospital procedures can sharply reduce the harm children suffer from opiates. The study, a yearlong collaboration between 14 U.S. children's hospitals, documented a 67 percent drop in harmful events caused by the pain relievers when these procedures were implemented. "Our collaborative aim was to decrease adverse drug event rates by 50 percent," Sharek said. "We far exceeded that, which was very exciting."

The findings are published in the October issue of Pediatrics. The researchers focused on opiates ­ pain-relieving drugs in the morphine family ­ because they're widely used and harm young patients more often than other drugs. Forty percent of patients at children's hospitals across the U.S. receive opiates. The vast majority of harmful incidents from the drugs, such as constipation and skin itching, are relatively minor. But neither families nor doctors want such problems adding to kids' days in hospital.

Hospital teams followed standard protocols for weaning patients off long-term doses of opiates. They reduced prescription overrides in which nurses gave pain medications to children before double-checking with a pharmacist. And they worked hard to ensure that all caregivers had up-to-date drug lists when patients were admitted to hospital, transferred to new wards and sent home. The study physicians also routinely added medications to prevent constipation.

The researchers' efforts began paying off a few months after changes were instituted. Problems associated with opiates dropped, as the new practices spread through each hospital. In total, the team estimated 14,594 harmful events were averted in participating hospitals during the one-year study. The changes also saved hospitals money, since harmful events can be costly to resolve and often result in extended hospital stays. Visit here for the complete story


 

CRC screening before Medicare age could save millions in federal healthcare dollars

A screening program for colon cancer in patients starting ten years prior to Medicare eligibility, at age 55 instead of Medicare's 65, would save at least two dollars for every dollar spent, according to a new study presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando.

As people get older, their risk of developing polyps and colorectal cancer increases. Current guidelines recommend a screening colonoscopy for average risk individuals beginning at age 50. But for many uninsured Americans, a lack of health insurance coverage poses a barrier to screening. Medicare coverage for most Americans begins at age 65, creating a coverage gap.

In order to determine the effect of a lack of health coverage on screening and the cost effectiveness of screening uninsured patients, Dr. Jianjun Li and colleagues from Maimonides Medical Center in Brooklyn offered free colonoscopies to 248 consecutive patients (mean age 55) as part of a colorectal cancer screening program. Nearly 45 percent of patients had polyps. Five patients had early stage colon cancer, and 22 patients had polyps larger than 1 cm. These large polyps are felt to have a greater risk of harboring or developing into colorectal cancer than smaller polyps. The screening program cost a total of $390,000.

The researchers concluded that had these patients not been screened, and the cancers and polyps allowed to progress undetected—assuming the cost of treatment and screening would be delayed until the Medicare eligibility age of 65—the estimated costs would be $1,295,000. Click here


 

Factors other than antibiotics may raise risk of C. difficile infection: study

Infection with potentially deadly Clostridium difficile is often linked to antibiotic use, but new research suggests the drugs may be getting too much of the bad rap for the illness and that other factors may also be to blame. In a study of C. difficile infections among people living in the community – as opposed to those sickened by the bug while in hospital – McGill University researchers found that a significant proportion of those who got C. diff-related disease had not recently taken antibiotics.

Researchers analyzed health records for 836 Quebecers aged 65 or older living in the community who contracted C. difficile-related disease that landed them in the hospital with severe diarrhea and other symptoms.

They found that 53 percent had not taken antibiotics in the 45 days preceding hospitalization for their infection. Expanding the analysis further, the study showed 46 percent of subjects had not been exposed to the drugs for 90 days prior to being admitted. C. difficile is mainly known as a hospital-acquired infection, but the study participants had not been in hospital for at least three months before being admitted after being sickened by the infection, suggesting their disease was community-acquired.

"Essentially, what we were trying to address is the idea that only patients who have taken antibiotics get C. diff," Dr. Sandra Dial, a critical-care specialist at McGill said from Montreal. "And so what we wanted to examine was could we confirm that people get Clostridium difficile without antibiotic exposure." She said the main reason researchers looked at community-acquired C. difficile is because they thought "it could make the picture a little clearer than looking at it in a hospital where so many things are closely tied together."

Dial said C. difficile occurs most often among patients already in hospital because transmission is easier: patients are in close proximity, they are already ill and are often given antibiotics. In the community, cases are proportionately fewer and the circumstances needed for transmission are less prevalent, she said, so other factors must come into play. Those include people with underlying bowel disease, weakened immune systems and disruptions to "good" intestinal flora that normally would keep C. difficile from reproducing in large enough numbers that they produce a toxin and cause disease. Dial also believes use of antacids known as proton pump inhibitors may encourage serious infection because they strip away one of the body's defenses against the bug by limiting stomach acid production.

The recognition of other risk factors should act as a red flag for hospitals, said Dial, whose paper was published in this week's Canadian Medical Association Journal.

"So what we're saying is if patients, particularly elderly patients, who have any sort of bowel disorder present with severe diarrhea, still test them for C. diff even if you don't get a history that they've been in a hospital or that they've taken antibiotics in the recent past."

Dr. Andrew Simor, an infectious disease specialist at Sunnybrook Health Sciences Centre in Toronto, said doctors have long known that not all cases of C. difficile occur after taking antibiotics. The bacteria was identified as the cause of a particular illness in the 1880s, long before antibiotics were discovered, he said. "What's interesting in this paper, however, is the relatively big proportion" of patients who had not taken antibiotics, he said. "Almost half of her study population did not appear to have had prior antibiotic exposure."

Simor agreed that hospitals should be vigilant in testing for the disease when telltale symptoms are present, even in the absence of recent antibiotic use and hospitalization. (Canadian Press) Visit here for the complete story


 

Catholic Healthcare West posts stable financial performance in 2008

Catholic Healthcare West (CHW), the eighth largest health system in the nation and the largest not-for-profit hospital provider in California, has announced the results of its 2008 fiscal year, posting a net income of $170 million for the year ended June 30, compared to $891 million in the 2007 fiscal year, which included the effect of a change in accounting for unrealized gains and losses. This change in reporting rules for unrealized gains and losses on investments resulted in additional investment income of $194 million in FY07 that related to prior years.

Operating income for the not-for-profit hospital system in FY08 was $160 million compared to an operating income of $300 million in FY07. Revenues for FY08 increased 12 percent to $8.4 billion, compared to $7.8 billion in FY07. Across the 41-hospital system, adjusted admissions increased by 5.4 percent during the fiscal year, bringing its three-year increase to 12 percent. Results were released following a standard audit of financial statements.  

CHW's income statement was impacted during the year by a non-recurring item – a  mold remediation project at St. John's Regional Medical Center in Oxnard, CA – and several non-cash accounting entries, including the cost of restructuring debt and the aforementioned change in reporting rules for unrealized gains and losses on investments. Without these events, net income for the 2008 fiscal year would have been $485 million.

During FY08, CHW provided $508 million in community benefits and free care for the poor, including charity care, community grants, and free primary care, up from $501 million in FY07. Based on guidance from the Catholic Health Association, CHW does not count its Medicare shortfall as part of community benefits. The Medicare shortfall to CHW in FY08 was $459 million, bringing the total FY08 unreimbursed expense to $967 million for both patient care and proactive health improvement efforts.

CHW also reinvested nearly $800 million in capital improvements and technology, including the continued roll-out if its clinical information system to a number of facilities; construction of a new hospital in Merced, CA; new patient towers at Mercy San Juan Medical Center in Carmichael, CA, and St. Joseph's Medical Center in Stockton, CA; and expansions at Mercy Gilbert Medical Center in Gilbert, AZ, and Bakersfield Memorial Hospital in Bakersfield, CA. For more information, please visit www.chwHEALTH.org.


 

Study reveals that signs of heart disease are attributed to stress more frequently in women than men

Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.

"We know that there is a delay in diagnosing CHD in women and this is an important step forward in understanding why," said Alexandra J. Lansky, M.D., director of the Women's Health Initiative at CRF, director of Clinical Services at the Center for Interventional Vascular Therapy, a cardiologist at NewYork-Presbyterian Hospital/Columbia University Medical Center, and an associate professor of clinical medicine at Columbia University College of Physicians and Surgeons.

The investigation – "Gender Bias in the Diagnosis, Treatment, and Interpretation of CHD Symptoms: Two Experimental Studies with Internists and Family Physicians," was led by Gabrielle R. Chiaramonte, Ph.D., postdoctoral associate at the Weill Medical College of Cornell University and Clinical Fellow at NewYork-Presbyterian Hospital. The study examined the effects of patients' gender and the context of how CHD symptoms are presented (with/without mention of life stressors and anxiety) on primary care physicians' patient evaluations.

The researchers hypothesized that the presence of life stressors/anxiety would shift the interpretation of women's, but not men's, CHD symptoms, so that these would be perceived to have a psychogenic etiology. "The greater prevalence of anxiety disorders in women, along with the greater likelihood that women will discuss stressors with their physicians, and the overlap of CHD and anxiety symptoms, contribute to this shift in interpretation," Dr. Chiaramonte said.

As the investigators predicted, results showed a gender bias when CHD symptoms were presented in the context of stress, with fewer women receiving CHD diagnoses (15% versus 56%), cardiologist referrals (30% versus 62%), and prescriptions of cardiac medication (13% versus 47%) than men. No evidence of a bias was observed when CHD symptoms were presented without the stress. Results also showed that the presence of stress shifted the interpretation of women's chest pain, shortness of breath and irregular heart rate so that these were thought to have a psychogenic origin. By contrast, men's symptoms were perceived as organic whether or not stressors were present.

For more information, visit www.crf.org. For the complete story visit here


 

Reminder for nominations: HPN to recognize "Supply Chain-Focused CEOs" in January 2009 edition

Many industries outside of healthcare recognize and respect the value that effective and efficient supply chain management contributes to the top and bottom lines. Among healthcare providers, such recognition and support is growing, slowly but surely, from the top post in the executive suite.

That’s why Healthcare Purchasing News launched its yearly search for "supply chain focused CEOs four years ago. We wanted to locate forward-thinking men and women to share their insights with you, and you’ve helped us do that. In fact, we’ve profiled of 13 of them already since January 2005.

Well, it’s that time of the year again – time to nominate noteworthy hospital presidents/CEOs for HPN’s 5th Annual "S.U.R.E. Award for Supply Chain Focused CEOs" award. We’re looking to recognize chief executives who support, understand, recognize and empower the materials management department to do what needs to be done to achieve bottom-line savings and top-line revenue.

We ask you, our dedicated and loyal readers, to recommend worthy candidates for recognition in our January 2009 edition by e-mailing us reasons how and why your CEO deserves the spotlight – no more than a couple of paragraphs are needed for each of the four S.U.R.E. categories listed above that comprise the "SURE" acronym. Please describe how and why he or she supports, how and why he or she understands, how and why he or she recognizes and how and why he or she empowers the materials management department and its top executive.

For your nomination to qualify, please be sure to comply with our submission rules. Click here for details.

Nominations are due by Friday, November 7.

Thanks in advance.

 
 

 


back to home page